Table 3 Prioritization of outcomes.

From: A comparative 48 month randomized trial of clinical performance and wear of BISGMA based and BISGMA free nanoceramic resin composites

Prioritization of outcome

Outcome

Method of measure

Unit of measurement

Primary outcome: (Modified USPHS)

Anatomic form

Clinical evaluation

Alfa: Anatomic form ideal

Bravo: Restoration is under-contoured, without

dentin or base exposure.

Charlie: Restoration is under-contoured, without dentin or base exposure.restoration need replacement

Secondary outcomes

Color match

Clinical evaluation

Alfa: Matches tooth

Bravo: Acceptable mismatch

Charlie: Unacceptable mismatch

Marginal discoloration

Clinical evaluation

Alfa: No discoloration

Bravo: minor marginal discoloration without staining toward pulp

Charlie: Deep discoloration with staining toward pulp

Marginal adaptation

Clinical evaluation

Alfa: Closely adapted, no visible crevice

Bravo: Visible crevice, explorer will penetrate

Charlie: Crevice in which dentin is exposed

Secondary Caries

Clinical evaluation

Alfa: No active caries present

Bravo: Non-cavitated active caries is present in contact with the restoration

Charlie: Cavitated active caries is present in contact with the restoration

Surface Texture

Clinical evaluation

Alfa: As smooth as the surrounding enamel

Bravo: Surface rougher than enamel, clinically acceptable

Charlie: Surface unacceptably rough

Marginal Integrity

Clinical evaluation

Alfa: Restoration adapts closely to the tooth structure

Bravo: A visible crevice

Charlie: The explorer penetrates into the crevice

Postoperative sensitivity

Clinical evaluation

Alfa: No post-operative sensitivity

Bravo: Short term and tolerable post-operative sensitivity

Charlie: Intolerable post-operative sensitivity

Amount of restoration wear (2ry outcome)

A-Digital scanner (Geometrical Subtraction software)

B-Impression replica technique

(Nikolaos et al., in 2020)

Measuring unit: (Quantitative)

Linear deviation (mm)

Volumetric deviation (mm3)